Crescent Capital BDC (NASDAQ:CCAP – Free Report) had its price objective cut by Raymond James from $20.00 to $17.00 in a report published on Friday,Benzinga reports. They currently have an outperform rating on the stock.
A number of other equities research analysts have also commented on CCAP. Keefe, Bruyette & Woods lowered Crescent Capital BDC from an “outperform” rating to a “market perform” rating and decreased their price objective for the stock from $18.50 to $17.00 in a research report on Friday. Wells Fargo & Company reduced their price target on shares of Crescent Capital BDC from $16.00 to $15.00 and set an “equal weight” rating for the company in a research report on Friday. Two equities research analysts have rated the stock with a hold rating and three have issued a buy rating to the company. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $17.60.
Check Out Our Latest Stock Analysis on CCAP
Crescent Capital BDC Trading Down 3.3%
Crescent Capital BDC (NASDAQ:CCAP – Get Free Report) last issued its earnings results on Wednesday, May 14th. The company reported $0.45 EPS for the quarter, missing the consensus estimate of $0.52 by ($0.07). Crescent Capital BDC had a return on equity of 11.90% and a net margin of 37.32%. The business had revenue of $42.13 million during the quarter, compared to analyst estimates of $45.08 million. Equities analysts anticipate that Crescent Capital BDC will post 2.09 EPS for the current year.
Crescent Capital BDC Announces Dividend
The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, July 15th. Investors of record on Monday, June 30th will be given a dividend of $0.42 per share. The ex-dividend date of this dividend is Monday, June 30th. This represents a $1.68 dividend on an annualized basis and a yield of 10.89%. Crescent Capital BDC’s payout ratio is 84.42%.
Institutional Inflows and Outflows
A number of institutional investors and hedge funds have recently bought and sold shares of the company. Montag A & Associates Inc. purchased a new stake in shares of Crescent Capital BDC during the 4th quarter worth about $35,000. C M Bidwell & Associates Ltd. bought a new stake in shares of Crescent Capital BDC in the 4th quarter valued at approximately $39,000. Aquatic Capital Management LLC acquired a new position in Crescent Capital BDC in the fourth quarter worth approximately $129,000. Generation Capital Management LLC acquired a new position in Crescent Capital BDC in the fourth quarter worth approximately $192,000. Finally, Dynamic Technology Lab Private Ltd bought a new position in Crescent Capital BDC during the fourth quarter valued at approximately $218,000. Hedge funds and other institutional investors own 49.46% of the company’s stock.
About Crescent Capital BDC
Crescent Capital BDC, Inc is as a business development company private equity / buyouts and loan fund. It specializes in directly investing. It specializes in middle market. The fund seeks to invest in United States.
Featured Stories
- Five stocks we like better than Crescent Capital BDC
- Investing in the High PE Growth Stocks
- Nextracker’s Solar Surge: Will It Shatter Its All-Time High?
- Breakout Stocks: What They Are and How to Identify Them
- Savvy Investors Are Raising a Glass for Heineken Stock
- What is the FTSE 100 index?
- Top 4 ETFs for China Exposure After Tariff Relief
Receive News & Ratings for Crescent Capital BDC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Crescent Capital BDC and related companies with MarketBeat.com's FREE daily email newsletter.